Due to the potential protective role of IL4 toward the inflammatory processes occurring in the gut mucosa of CD patients, evaluating the potential of ILE to be used as another amino acid supplement for alleviating CD patients’ inflammation is of great importance. This evidence concerns the gene IL4 and Cowden disease.